BOLT Latest News, Press Relases and Analysis

All

Press Releases

22 days ago - By: Zacks Investment Research - Mentions: FENC

Bolt Biotherapeutics, Inc. (BOLT) Reports Q3 Loss, Beats Revenue Estimates

22 days ago - By: Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update

22 days ago - By: Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update

a month ago - By: Zacks Investment Research - Mentions: PTGX

Bolt Biotherapeutics, Inc. (BOLT) Expected to Beat Earnings Estimates: Should You Buy?

2 months ago - By: Benzinga - Mentions: SCLX TSHA RVPH PALI ...

12 Health Care Stocks Moving In Thursday's Intraday Session

4 months ago - By: The Motley Fool

Bolt Revenue Jumps 39 Percent in Q2

2 months ago - By: Benzinga - Mentions: COOP WOOF EFX RKT ...

Fidus Investment, Rocket Companies And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

2 months ago - By: Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics Provides Update on BDC-4182 and Extends Cash Runway into 2027

2 months ago - By: Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics Provides Update on BDC-4182 and Extends Cash Runway into 2027

4 months ago - By: Zacks Investment Research - Mentions: ELMD

Bolt Biotherapeutics, Inc. (BOLT) Reports Q2 Loss, Tops Revenue Estimates

4 months ago - By: Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

4 months ago - By: Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

4 months ago - By: Zacks Investment Research - Mentions: PHAT

Phathom Pharmaceuticals, Inc. (PHAT) Reports Q2 Loss, Tops Revenue Estimates

7 months ago - By: Zacks Investment Research - Mentions: IMNM

Bolt Biotherapeutics, Inc. (BOLT) Reports Q1 Loss, Tops Revenue Estimates

7 months ago - By: Zacks Investment Research - Mentions: ARCT

Arcturus Therapeutics (ARCT) Reports Q1 Loss, Tops Revenue Estimates

7 months ago - By: Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

7 months ago - By: Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

7 months ago - By: Yahoo Finance - Mentions: KRYS JAZZ HEPA TECH

Biotech Alert: Searches spiking for these stocks today

7 months ago - By: Zacks Investment Research - Mentions: PRTA

Prothena (PRTA) Reports Q1 Loss, Misses Revenue Estimates

7 months ago - By: Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics to Host KOL Conference Call and Webcast to Discuss BDC-3042 Phase 1 Results and Corporate Updates

7 months ago - By: Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics Presents Preclinical Results for Next-Generation Boltbody™ ISACs targeting CEA and PD-L1 at AACR Annual Meeting 2025

7 months ago - By: Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025

7 months ago - By: Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025

8 months ago - By: Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics to Present Data from Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025

8 months ago - By: Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics to Present Data from Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025

9 months ago - By: Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update

9 months ago - By: Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update

9 months ago - By: Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics to Participate in Upcoming March Conferences

10 months ago - By: Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics, Inc. Provides Update on Global Cancer Immunotherapy Co-Development with Toray Industries, Inc.

10 months ago - By: Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics, Inc. Provides Update on Global Cancer Immunotherapy Co-Development with Toray Industries, Inc.

a year ago - By: Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

a year ago - By: Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics Presents Updated Preclinical Data for BDC-4182 and Key Learnings from Phase 1 Dose-Escalation Trial of BDC-1001 at SITC 39th Annual Meeting

BOLT BIOTHERAPEUTICS INC (BOLT) Stock News

BOLT Latest News, Press Relases and Analysis